-
Your selected country is
fi
- Change country/language
Old Browser
Your account has been put on hold due to inactivity. To re-activate, check your account information and make all necessary updates.
Looks like you're visiting us from {{countryName}}.
Would you like to remain on the current country site or be redirected to one based on your location?
Your account has been put on hold due to inactivity. To re-activate, check your account information and make all necessary updates.
CLL Phenotyping with BD Rhapsody™ Targeted Panels and BD® AbSeq Assays
Chronic Lymphoid Leukemia (CLL), the most common form of leukemia in adults, is often characterised by progressive accumulation of incompetent lymphocytes in blood and bone marrow. Recent bulk RNA studies suggested that there are heterogeneities in CLL samples, prompting the need for single-cell RNA sequencing to study the underlying transcriptional profile.
This presentation shows how the BD Rhapsody(TM) Single Cell Analysis System can be used to simultaneously evaluate gene and protein expression. 32 proteins and ~500 genes were simultaneously analysed in single cells, revealing not only significant heterogeneity among CLL samples but also new cell types that were not previously associated with the disease.
Dowload "Exploring tumor heterogeneity of chronic lymphocytic leukemia using single cell multiomics" data sheet.
BD, the BD Logo, BD Rhapsody are trademarks of Becton, Dickinson and Company © 2019 BD and its subsidiaries. All rights reserved.
For research use only. Not for use in diagnostic or therapeutic procedures.
Report a Site Issue
This form is intended to help us improve our website experience. For other support, please visit our Contact Us page.